01 December 2006
Nitric oxide's pulsatile release in lobster heart and its regulation by opiate signaling: pesticide interference.
Federico M. Casares, Kirk J. Mantione, Kevin Oh, Ray Lee, George B. StefanoMed Sci Monit 2006; 12(12): BR373-378 :: ID: 469529
Abstract
BACKGROUND: Data is emerging in the human and invertebrate literature demonstrating that mu opiate receptors and morphine are present in cardiovascular tissues in diverse animals, including human tissues, where they may be exerting a cardioregulatory role via stimulation of constitutive nitric oxide (NO) production. MATERIAL/METHODS: NO release from lobster heart was evaluated without stimulation and after morphine exposure using a real-time NO-specific amperometric probe. In addition, real time NO release was evaluated after treatment with low doses of widely used pesticides (e.g., pyrethroids). Real time RT-PCR was used to investigate the presence of mu opiate receptor subtypes in lobster heart. RESULTS: Basal NO release occurs in lobster heart at the nanomolar level. Morphine enhanced this level of release; naloxone (an opiate antagonist) blocked it, as did exposure to the NO synthase inhibitor L-NAME. In addition, treatment with the pyrethroids, permethrin and resmethrin, abrogated constitutive NO release from lobster heart. Finally, by way of real time RT-PCR we were able to demonstrate the presence of the micro(3) opiate receptor subtype in lobster heart. CONCLUSIONS: Rhythmic NO bursts appear to be involved in normal cardiac muscle activity in Homarus americanus. Lobster heart contains morphinergic signaling components capable of slowing down its beating rate via NO production. In addition, compounds such as pyrethroid pesticides may alter normal cardiac activity by interfering with constitutive NO production and thus, depressing basal NO levels. This may ultimately make these animals more susceptible to environmental assaults/toxins.
Keywords: Feedback, DNA Primers - genetics, Base Sequence, Models, Biological, Myocardium - metabolism, Nephropidae - metabolism, Nitric Oxide - biosynthesis, Pesticides - toxicity, Pyrethrins - toxicity, Receptors, Opioid, mu - metabolism, Signal Transduction - drug effects
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952